1823-76-3 Usage
Description
2-hydroxyimino-1-(4-methoxyphenyl)ethanone, also known as carvacrol oxime, is a chemical compound with a molecular formula C10H11NO2. It is derived from carvacrol, a natural compound found in oregano and other plants. This versatile compound possesses antibacterial, antifungal, and antioxidant properties, making it a valuable asset in various industries.
Uses
Used in Pharmaceutical Industry:
2-hydroxyimino-1-(4-methoxyphenyl)ethanone is used as an active pharmaceutical ingredient for its potential therapeutic effects in treating infections and inflammatory conditions. Its natural origin and broad-spectrum antimicrobial activity contribute to its appeal in developing new drugs for various health applications.
Used in Food Industry:
In the food industry, 2-hydroxyimino-1-(4-methoxyphenyl)ethanone is used as a food additive for its preservative qualities. Its ability to inhibit the growth of bacteria and fungi helps maintain the freshness and safety of various food products, extending their shelf life and improving overall food quality.
Used in Drug Development:
2-hydroxyimino-1-(4-methoxyphenyl)ethanone is utilized in the research and development of new drugs, capitalizing on its potential to combat infections and inflammation. Its multifaceted properties allow for exploration in various therapeutic areas, offering promising avenues for novel drug discovery.
Used in Antioxidant Formulations:
As an antioxidant, 2-hydroxyimino-1-(4-methoxyphenyl)ethanone is used in various formulations to protect against oxidative stress and related conditions. Its capacity to neutralize free radicals and reduce oxidative damage makes it a valuable component in health supplements and skincare products.
Check Digit Verification of cas no
The CAS Registry Mumber 1823-76-3 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,8,2 and 3 respectively; the second part has 2 digits, 7 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1823-76:
(6*1)+(5*8)+(4*2)+(3*3)+(2*7)+(1*6)=83
83 % 10 = 3
So 1823-76-3 is a valid CAS Registry Number.
InChI:InChI=1/C9H9NO3/c1-13-8-4-2-7(3-5-8)9(11)6-10-12/h2-6,12H,1H3
1823-76-3Relevant articles and documents
Arylglyoxal oximes as putative C-nucleophiles in eliminative nucleophilic substitution process
Tsyganov, Dmitry V.,Samet, Alexander V.,Dorovatovskii, Pavel V.,Khrustalev, Victor N.,Semenov, Victor V.
, p. 296 - 298 (2019/06/13)
Reaction of arylglyoxal oximes ArCOCH=NOH (Ar = 4-MeOC6H4, Ph) with 5-arylfurazanopyrazines proceeds as vicarious nucleophilic substitution of hydrogen in pyrazine ring with the elimination of hyponitrous acid, affording 5-(aroylmethylidene)-6-aryl-4H-furazano[3,4-b]pyrazines. Structure of the product was confirmed by X-ray diffraction.
Synthesis and biological activities of 2,4-diaminopteridine derivatives
Ma, Fei,Lue, Gang,Zhou, Wei-Fen,Wang, Qiu-Juan,Zhang, Yi-Hua,Yao, Qi-Zheng
experimental part, p. 274 - 280 (2009/09/06)
Substituted 2,4-diaminopteridine derivatives 10a-10l were prepared in moderate to good yield. Their structures were confirmed by 1H-NMR and MS spectroscopy, as well as by elemental analysis. Their inhibitory properties against inducible nitric oxide synthase (iNOS) were evaluated in vitro. Biological tests indicated that compound 10a, 10d, 10e, 10h, 10i, and 10l showed potent inhibitory activities similar to that of methotrexate (MTX), while the activities of compound 10b, 10c, 10f, 10g, 10j, and 10k are stronger than MTX. Two compounds, i. e., 10b (IC50 = 18.85 μM) and 10i (IC 50 = 24.08 μM) were further studied for their effect on septic shock in rats and immunologically liver injured mice (in vivo). The results demonstrated that 10b and 10i had the capacity to increase the blood pressure in septic shock and showed notable protective activities on immunological hepatic injury.
One-pot synthesis of 3-amino-4-aryl- and 3-amino-4-hetarylfurazans
Sheremetev
, p. 1057 - 1059 (2007/10/03)
A "one pot" method for the synthesis of 3-amino-4-aryl- and 3-amino-4-hetarylfurazans from β-aryl- and 4-β-hetaryl-β-oxo acid esters was developed.